Psychedelicdrugs
Latest
DEA approves MDMA study for the terminally ill
MDMA is widely used both on and off festival grounds. But the drug is quietly making a comeback as a therapeutic aid. Last week, the DEA approved a clinical trial that will use a combination of the psychedelic drug and psychotherapy to treat anxiety associated with terminal illnesses. Multidisciplinary Association for Psychedelic Studies (MAPS) has initiated the study as part of their on-going efforts to validate the effectiveness of MDMA in a scientific setting. This isn't the first time it's been used to assist psychotherapy. But if the study is successful, it will introduce a new use for the drug.
